MedPath

Comparison of effectiveness of Oleanzepine versus Melaton in for treatment of delirium in critically Ill patients

Not Applicable
Conditions
Health Condition 1: F59- Unspecified behavioral syndromes associated with physiological disturbances and physical factors
Registration Number
CTRI/2021/05/033908
Lead Sponsor
Self Sponsored
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Written and informed consent from patients

2) Critically ill patients Age >18 or < 60

3) All patients having delirium assessed through CAM-ICU scale were considered eligible for the study

4) Patients who are verbally responsive, and not having demenî??a wereincluded in the study.

5) Diagnosed within five hours of onset of delirium

Exclusion Criteria

1.If they had less than 5 days of ICU stay

2.Sensitivity reaction to the melatonin and olanzapine supplement.

3.Pregnancy

4.Previous history of seizure or active seizure

5.Unable to assess for delirium

6.History of severe cognitive or neurodegenerative disease

7.Unable to communicate in English or Hindi

8.Absolute contraindication to enteral nutrition

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath